Trial Profile
Phase 2/3, Open-Label, Comparative Trial Of Azithromycin Plus Chloroquine Versus Artemether-Lumefantrine For The Treatment Of Uncomplicated Plasmodium Falciparum Malaria In Children In Africa
Status:
Completed
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Chloroquine/azithromycin (Primary) ; Artemether/lumefantrine
- Indications Falciparum malaria
- Focus Therapeutic Use
- Sponsors Pfizer
- 06 Nov 2014 New trial record